You are here

  • Home
  • Archive
  • Volume 67, Issue 1
  • Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

Article metrics

Article menu
Cystic fibrosis
Original article
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
Free

 

Online download statistics by month:

Online download statistics by month: August 2011 to March 2024

AbstractFullPdf
Aug 2011470135133
Sep 20111458073
Oct 20111054845
Nov 201139281129
Dec 201170166126
Jan 20121137886304
Feb 2012505133129
Mar 20123676982
Apr 20123185889
May 2012344139155
Jun 2012328122133
Jul 20122759983
Aug 20122398961
Sep 201229110381
Oct 2012246106103
Nov 20122768989
Dec 20121796557
Jan 201329712596
Feb 201322111785
Mar 2013241120112
Apr 20132119990
May 201316887103
Jun 20131754249
Jul 20131884645
Aug 20131294434
Sep 20131273741
Oct 20131536259
Nov 20131606244
Dec 20131214538
Jan 20141353439
Feb 20141232322
Mar 20142121522
Apr 20141233415
May 2014981513
Jun 2014981622
Jul 2014902113
Aug 20147913250
Sep 2014983424
Oct 2014971414
Nov 20141022223
Dec 20141102613
Jan 20157454132
Feb 201511945259
Mar 2015149100672
Apr 201510486239
May 20156173322
Jun 20155759932
Jul 20154854642
Aug 20155561837
Sep 201510538149
Oct 2015743623
Nov 2015944535
Dec 2015975028
Jan 2016924429
Feb 2016565135
Mar 2016383634
Apr 2016586048
May 2016503820
Jun 2016515135
Jul 2016833130
Aug 20161683128
Sep 20161302827
Oct 20161414247
Nov 20161675432
Dec 20161242723
Jan 20171022528
Feb 2017543932
Mar 2017406124
Apr 2017309437
May 2017307232
Jun 2017296220
Jul 2017935124
Aug 20171005914
Sep 20171208226
Oct 20171408730
Nov 20171268018
Dec 20171167229
Jan 20181155938
Feb 201816210319
Mar 201814511443
Apr 201832527714
May 20181208429
Jun 2018107736
Jul 201882547
Aug 20181098912
Sep 2018129879
Oct 201816612015
Nov 201820817424
Dec 201821214425
Jan 20191138914
Feb 20191238921
Mar 20191027334
Apr 2019723427
May 2019653236
Jun 2019462932
Jul 2019473932
Aug 2019533029
Sep 2019544415
Oct 20191229034
Nov 2019854733
Dec 2019733116
Jan 2020715429
Feb 2020855130
Mar 2020965441
Apr 2020672426
May 2020975591
Jun 2020483819
Jul 2020514210
Aug 2020553914
Sep 2020735623
Oct 2020926725
Nov 2020925426
Dec 2020915834
Jan 2021715926
Feb 2021896138
Mar 20211217938
Apr 20211046632
May 20211107650
Jun 2021494932
Jul 2021606030
Aug 2021585739
Sep 2021808017
Oct 202113711165
Nov 202119915570
Dec 2021957632
Jan 20221268321
Feb 2022998329
Mar 20221027866
Apr 20221096941
May 20221439880
Jun 2022896237
Jul 2022715218
Aug 2022805223
Sep 2022755954
Oct 202213710777
Nov 2022886322
Dec 2022936228
Jan 20231349830
Feb 2023946526
Mar 20231199620
Apr 2023794117
May 2023925544
Jun 2023664110
Jul 2023573332
Aug 2023986724
Sep 2023654720
Oct 202316813038
Nov 202318015332
Dec 202319116023
Jan 20242348982
Feb 20241188045
Mar 202415276137
Total21034164116587